Developmental Diseases of the Nervous System

  • Suresh Kotagal
  • Alma R. Bicknese
  • Marthand Eswara
  • Glen A. Fenton
  • Thomas J. Geller
  • Dorothy K. Grange
  • David S. Martin
  • Michael A. Nigro
  • Thomas Pittman


This chapter covers a varied group of disorders of inherited, postinfectious, ischemic, or undetermined etiology All lead to abnormal development of the nervous system. Some disorders have been selected because of the challenge they pose in diagnosis and management, and others because they illustrate important concepts in neuroembryology or pathophysiology.


Tuberous Sclerosis Tuberous Sclerosis Complex Neural Tube Defect Williams Syndrome Arachnoid Cyst 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Burnelli S, Faiella A, Capra V, et al.: Germline mutations in the homeobox gene EMX2 in patients with severe schizencephaly. Nat Genet 1996, 12:94–96.CrossRefGoogle Scholar
  2. 2.
    Dobyns W, Reiner O, Carrozzo R, Ledbetter D: Lissencephaly: a human brain malformation associated with deletion of the LIS-1 gene located on chromosome 17p13. JAMA 1993, 270: 2838–2842.PubMedCrossRefGoogle Scholar
  3. 3.
    Guttman RH, Collins FS: Recent progress toward understanding the molecular biology of von Recklinghausen’s neurofibromatosis. Ann Neural 1992, 31: 555–561.CrossRefGoogle Scholar
  4. 4.
    Use of folic acid for prevention of spina bifida and other neural tube defects-1983–1991. MMWR 1991, 40 (30): 513–516.Google Scholar
  5. 5.
    Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 1992, 41 (RR-14): 1–7.Google Scholar
  6. 6.
    Watson WJ, Chescheir NC, Katz VL, Seeds JW: The role of ultrasound in evaluation of patients with elevated maternal serum a-fetoprotein: a review. Obstet Gynecol 1991, 78 (1): 123–128.PubMedGoogle Scholar
  7. 7.
    Hunter AGW: Brain and Spinal Cord. In Human Malformations and Related Anomalies, vol 2. Edited by Stevenson RE, Hall JG, Goodman RM. New York: Oxford University Press; 1993: 109–137.Google Scholar
  8. 8.
    Romano PS, Waitzman NJ, Scheffler RIVI, Randy D: Folic acid fortification of grain: an economic analysis. Am J Public Health 1995, 85 (5): 667–676.PubMedCrossRefGoogle Scholar
  9. 9.
    Juriloff DM, Harris MJ: Mouse models for neural tube closure defects. Hum Mol Genet 2000, 9 (6): 993–1000.PubMedCrossRefGoogle Scholar
  10. 10.
    Shapiro K: Encephalocele. In Birth Defects Encyclopedia. Edited by Buyse ML. Dover, MA: Center for Birth Defects Information Services in association with Blackwell Scientific Publications; 1990: 614–615.Google Scholar
  11. 11.
    Marin-Padilla M. Cephalic axial skeletal-neural dysraphic disorders: embryology and pathology. Can J Neurol Sci 1991, 18 (2): 153–169.PubMedGoogle Scholar
  12. 12.
    Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM: Folate levels and neural tube defects: implications for prevention. DAMA 1995, 274 (21): 1698–1702.CrossRefGoogle Scholar
  13. 13.
    Estin D, Cohen AR: Caudal agenesis and associated caudal spinal cord malformations. Neurosurgery Clinics of North America 1995, 6 (2): 377–391.PubMedGoogle Scholar
  14. 14.
    Johnston MC: Understanding human embryonic development. In Human Malformations and Related Anomalies, vol 1. Edited by Stevenson RE, Hall JG, Goodman RIVI. New York: Oxford University Press; 1993: 31–63.Google Scholar
  15. 15.
    Gellis SS, Feingold M, Tunnessen WW Jr, Raettig JA: Caudal regression syndrome: picture of the month. Am JDiseases Childhood 1968, 116: 407–408.Google Scholar
  16. 16.
    Escobar LF, Weaver DD: Caudal regression syndrome. In Birth Defects Encyclopedia. Edited by Buyse L. Dover, MA: Center for Birth Defects Information Services in association with Blackwell Scientific Publications; 1990: 296–297.Google Scholar
  17. 17.
    Jones KL: Smith’s Recognizable Patterns of Human Malformation, edn 4. Philadelphia: WB Saunders; 1988.Google Scholar
  18. 18.
    Welch JP, Aterman K: The syndrome of caudal dysplasia: a review, including etiologic considerations and evidence of heterogeneity. Pediatr Pathol 1984, 2: 313–327.PubMedCrossRefGoogle Scholar
  19. 19.
    Volpe JJ, ed: Neurology of the Newborn edn 3. Philadelphia: WB Saunders; 1994.Google Scholar
  20. 20.
    Hamada H, Oki A, Tsunoda H, Kubo T: Prenatal diagnosis of holoprosencephaly by transvaginal ultrasonography in the first trimester. Asia Oceania J Obstet Gynaecol 1992, 18: 125–129.PubMedCrossRefGoogle Scholar
  21. 21.
    Johnston MC, Bronsky PT: Prenatal cranio-facial development: new insights on normal and abnormal mechanisms. Crit Rev Oral Biol Med 1995, 6: 25–79.PubMedCrossRefGoogle Scholar
  22. 22.
    Johnston MC, Bronksy PT: Animal models of human cranio-facial malformations. J Craniofac Genet Dev Biol 1991, 11: 277–291.PubMedGoogle Scholar
  23. 23.
    Muenke M, Gurrieri F, Bay C, Yi DH, et al.: Linkage of a human brain malformation, familial holoprosencephaly, to chromosome 7, and evidence for genetic heterogeneity. Pro Natl Acad Sci USA 1994, 91:8102–8106.Google Scholar
  24. 24.
    Gorlin RJ, Cohen MM Jr, Levin LS: Syndromes of the Head and Neck. New York: Oxford University Press; 1990.Google Scholar
  25. 25.
    Todorov AB, Scott CI Jr, Warren AE, Leeper JD: Developmental screening tests in achondroplasia. Am J Med Genet 1981, 9: 19–23.PubMedCrossRefGoogle Scholar
  26. 26.
    Pauli RM, Scott CI, Wassman ER, et al.: Apnea and sudden unexpected death in infants with achondroplasia. J Ped 1984, 104(3):342–348.Google Scholar
  27. 27.
    Reid CS, Pyeritz RE, Kopits SE, et al.: Cervicomedullary compression in young patients with achondroplasia: value of comprehensive neurologic and respiratory evaluation. JPed 1987, 110(4):522–530.Google Scholar
  28. 28.
    Seashore MR, Cho S, Desposito F, et al.: Health supervision for children with achondroplasia. Pediatrics 1995, 95(3):443–451.Google Scholar
  29. 29.
    Bellus GA, Hefferon TW, Ortiz de Luna RI, et al.: Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am JHum Genet 1995, 56:368–373.Google Scholar
  30. 30.
    Shiang R, Thompson LN, Zhu Y-Z, et al.: Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994, 78:335–342.Google Scholar
  31. 31.
    Bicknese AR, Sheppard AM, O’Leary DDM, Pearlman AL: Thalamocortical afferents extend along a chondroitin sulfate proteoglycan-enriched pathway coincident with the neocortical subplate and distinct from the efferent pathway. J Neurosci 1994, 14 (6): 3500–3510.Google Scholar
  32. 32.
    Rakic P: Mode of cell migration to the superficial layers of fetal monkey neo-cortex. J Comp Neural 1972, 145: 61–83.CrossRefGoogle Scholar
  33. 33.
    Dobyns WB, Gilbert EF, Opitz JM: Further comments on the lissencephaly syndromes. Am J Med Genet 1985, 22: 197–211.PubMedCrossRefGoogle Scholar
  34. 34.
    Aicardi J: The agyria-pachygyria complex: a spectrum of cortical malformations. Brain Devel 1991, 13 (1): 1–8.CrossRefGoogle Scholar
  35. 35.
    Dobyns W, Truwit C: Lissencephaly and other malformations of cortical development: 1995 update. Neuropediatr 1995, 26: 132–147.CrossRefGoogle Scholar
  36. 36.
    Barkovich A, Koch T, Carrol C: The spectrum of lissencephaly: report of ten patients analysed by magnetic resonance imaging. Ann Neurol 1991, 30 (2): 139–146.PubMedCrossRefGoogle Scholar
  37. 37.
    Dieker H, Edwards R, ZuRhein G, et al.: The lissencephaly syndrome. Birth Defects 1969, 5(2):53–64.Google Scholar
  38. 38.
    Dobyns W, Reiner O, Carrozzo R, Ledbetter D: Lissencephaly: a human brain malformation associated with deletion of the LIST gene located at chromosome 17p13. JAMA 1993, 270 (23): 2838–2842.PubMedCrossRefGoogle Scholar
  39. 39.
    Reiner O, Albrecht U, Gordon M, et al.: Lissencephaly gene (LIS1) expression in the CNS suggests a role in neuronal migration. J Neurosci 1995, 15(5):3730–3738.Google Scholar
  40. 40.
    Qin J, Mizuguchi M, Itoh M: Immunohistochemical expression of doublecortin in the human cerebrum: comparison of normal development and neuronal migration disorders. Brain Res 2000, 863 (1–2); 225–232.PubMedCrossRefGoogle Scholar
  41. 41.
    Pinard J, Motte J, Chiron C, et al.: Subcortical laminar heterotopia and lissencephaly in two families: a single X linked dominant gene. J Neural Neurosurg Psychiat 1994, 57:914–920.Google Scholar
  42. 42.
    Gleeson JG, Allen KM, Fox JW, Lamperti ED, et al.: Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 1998, 92(1):63–72.Google Scholar
  43. 43.
    Altman N, Palasis S, Pacheco-Jacome E: Advanced magnetic resonance imaging of disorders of neuronal migration and sulcation. Internat Pediat 1995, 10 (suppl 1): 16–25.Google Scholar
  44. 44.
    Dobyns W: The neurogenetics of lissencephaly. Neurol Clin 1989, 7 (1): 89–105.PubMedGoogle Scholar
  45. 45.
    Gelot A, Billette de Villemeur T, Bordarier C, et al.: Developmental aspects of type II lissencephaly: comparative study of dysplastic lesions in fetal and postnatal brains. Acta Neuropathol 1995, 89:72–84.Google Scholar
  46. 46.
    Byrd S, Osborn R, Radkowski M: The MR evaluation of pachygyria and associated syndromes. EurJ Radiol 1991, 12: 53–59.CrossRefGoogle Scholar
  47. 47.
    Barkovich A, Rowley H, Bollen A: Correlation of prenatal events with the development of polymicrogyria. Am J Neuroradiol 1995, 16: 822–827.PubMedGoogle Scholar
  48. 48.
    Hayward JC, Titelbaum DS, Clancy RR, Zimmerman RA: Lissencephalypachygyria associated with congenital cytomegalovirus infection. J Child Neurol 1991, 6 (4): 109–114.PubMedCrossRefGoogle Scholar
  49. 49.
    Kuzniecky R, Andermann F, Guerrino R: Infantile spasms: an early epileptic manifestation in some patients with the congenital bilateral perisylvian syndrome. J Child Neurol 1994, 9: 420–423.PubMedCrossRefGoogle Scholar
  50. 50.
    Becker P, Dixon A, Troncoso J: Bilateral opercular polymicrogyria. Ann Neurol 1989, 25 (1): 90–92.PubMedCrossRefGoogle Scholar
  51. 51.
    Myers R: Cerebral ischemia in the developing primate fetus. Biomed Biochim Acta 1989, 48 (2/3): 5137–142.Google Scholar
  52. 52.
    Dominguez R, Aguirre Vila-Coro A, Slopis J, Bohan T: Brain and ocular abnormalities in infants with in utero exposure to cocaine and other street drugs. Am J Dis Child 1991, 145 (6): 688–695.PubMedGoogle Scholar
  53. 53.
    Stewart R: Ventral porencephaly: a posterior cerebral defect associated with multiple congenital anomalies. Acta Neuropathol 1978, 42: 231–235.PubMedCrossRefGoogle Scholar
  54. 54.
    Brunch S, Faiella A, Capra V, et al.: Germline mutating in the homebox gene EMX2 in patients with severe schizencephaly. Nat Genet 1996, 12:94–96.Google Scholar
  55. 55.
    Robinson R: Familial schizencephaly. Devel Med Child Neurol 1991, 33: 1010–1012.CrossRefGoogle Scholar
  56. 56.
    Barkovich A, Chuang S, Norman D: MR of Neuronal Migration Anomalies. Am J Roentgen 1988, 150 (1): 179–187.CrossRefGoogle Scholar
  57. 57.
    Norman M, Ludwin S: Congenital Malformations of the Nervous System. In Textbook of Neuropathology edn 2. Edited by Davis R, Robertson D. Baltimore: Williams and Wilkins; 1991: 207–280.Google Scholar
  58. 58.
    Layton DD: Heterotopic cerebral gray matter as an epileptogenic focus. JNeuropathol Exp Neural 1962, 21: 244–249.CrossRefGoogle Scholar
  59. 59.
    Lemire RJ, Loeser JD, Leech RW, Alvord EC: Forebrain Cortex. In Normal and Abnormal Development of the Nervous System. New York: Harper & Row; 1975: 251–253.Google Scholar
  60. 60.
    Kubo S, Kishino T, Sutuke N, et al.: A neonatal case of hydranencephaly caused by obstruction of the aortic arch. J Perinatol 1994, 14:483–486.Google Scholar
  61. 61.
    Velasco ME, Brown JA, Kini J, Ruppert ES: Primary congenital rhabdoid tumor of the brain with neoplastic hydranencephaly. Child’s Nery Syst 1993, 9: 185–190.Google Scholar
  62. 62.
    Hashimoto T, Fukuda K, Endo S, Miyazaki M, et al.: Circadian rhythm in patients with hydranencephaly. J Child Neural 1992, 7:188–194.Google Scholar
  63. 63.
    Williams JC, Barratt-Boyes BG, Lowe JB: Supravalvular aortic stenosis. Circulation 1961, 24: 1311–1318.PubMedCrossRefGoogle Scholar
  64. 64.
    Morris CA, Demsey SA, Leonard CO, et al.: Natural history of Williams syndrome: physical characteristics. J Pediat 1988, 113:318–326.Google Scholar
  65. 65.
    Sadler LS, Robinson LK, Verdaasdonk KR, Gingell R: The Williams syndrome: evidence for possible autosomal dominant inheritance. Am J Med Genet 1993, 47: 468–470.PubMedCrossRefGoogle Scholar
  66. 66.
    Ewart AK, Morris CA, Atkinson D, et al.: Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nature Genet 1993, 5:11–16.Google Scholar
  67. 67.
    Holm VA, Cassidy SB, Butler MG, et al.: Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993, 91:398–402.Google Scholar
  68. 68.
    Nicholls RD, Knoll JHM, Butler MG, et al.: Genetic imprinting suggested by maternal heterodisomy in non-deletion Prader-Willi syndrome. Nature 1989, 342:281–285.Google Scholar
  69. 69.
    Jones KL: Smith’s Recognizable Patterns of Human Malformation, edn 4. Philadelphia: WB Saunders; 1988: 170–173.Google Scholar
  70. 70.
    Clayton-Smith J: Clinical research on Angelman syndrome in the United Kingdom: observations on 82 affected individuals. Am J Med Genet 1993, 46: 12–15.PubMedCrossRefGoogle Scholar
  71. 71.
    Fryburg JS, Breg WR, Lindgren V: Diagnosis of Angelman syndrome in infants. Am J Med Genet 1991, 38: 58–64.PubMedCrossRefGoogle Scholar
  72. 72.
    Rougeulle C: Angelman syndrome: how many genes to remain silent? Neurogenet 1998, 1 (4): 229–237.CrossRefGoogle Scholar
  73. 73.
    Williams CA, Frias JL: The Angelman (“Happy Puppet”) syndrome. Am J Med Genet 1982, 11: 453–460.PubMedCrossRefGoogle Scholar
  74. 74.
    Raffel C, McComb JG: Arachnoid Cysts. In Pediatric Neurosurgery Surgery of the Developing Nervous System. edn 3. Philadelphia: WB Saunders; 1994: 104–110.Google Scholar
  75. 75.
    Oberbauer RW, Haase J, Pucher R: Arachnoid cysts in children: a European co-operative study. Childs Nery Sys 1992, 8 (5): 281–286.CrossRefGoogle Scholar
  76. 76.
    Ciricillo SF, Cogen PH, Harsh GR, Edwards MSB: Intracranial arachnoid cysts in children: a comparison of the effects of fenestration and shunting. JNeurosurg 1991, 74: 230–235.CrossRefGoogle Scholar
  77. 77.
    McLone DG, Naidich TP: The Tethered Spinal Cord. In Disorders of the Developing Nervous System: Diagnosis and Treatment. Boston: Blackwell Scientific Publications; 1986: 71–96.Google Scholar
  78. 78.
    Lemire RJ, Loeser JD, Leech RW, et al.: Normal and Abnormal Development of the Human Nervous System. New York: Harper & Row; 1975:71–83.Google Scholar
  79. 79.
    Kanev PM, Park TS: Dermoids and dermal sinus tracts of the spine. Neurosurg Clin North Am 1995, 6 (2): 359–366.Google Scholar
  80. 80.
    Steinbok P: Dysraphic lesions of the cervical spinal cord. Neurosurg Clin North Am 1995, 6 (2): 367–376.Google Scholar
  81. 81.
    Dias MS, Pang D: Split cord malformations. Neurosurg Clin North Am. 1995, 6 (2): 339–358.Google Scholar
  82. 82.
    Beardmore HE, Wiggelsworth FW: Vertebral anomalies and alimentary duplications. Pediatr Clin North Am 1958, 5: 457–474.Google Scholar
  83. 83.
    Perlman JM, Volpe JJ: Intraventricular hemorrhage in extremely small premature infants. AJDC 1986, 140: 1122–1124.PubMedGoogle Scholar
  84. 84.
    Volpe JJ: Neurology of the Newborn. Philadelphia: WB Saunders; 1995: 403–463.Google Scholar
  85. 85.
    Shinnar S, Gammon K, Bergman EW, et al.: Management of hydrocephalus in infancy: use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts. JPediatr 1985, 107:31–37.Google Scholar
  86. 86.
    Ventriculomegaly Trial Group: Randomised trial of early tapping in neonatal posthaemorrhagic ventricular dilatation: results at 30 months. Arch Dis Child 1994, 70: F129 - F136.Google Scholar
  87. 87.
    Papile L, Burstein J, Burstein R, Koffler H: Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 gm. J Pediatr 1978, 92: 529–534.PubMedCrossRefGoogle Scholar
  88. 88.
    Anwar M, Doyle AJ, Kadam S, et al.: Management of posthemorrhagic hydrocephalus in the preterm infant. J Ped Surg 1986, 21:334–337.Google Scholar
  89. 89.
    Whitelaw A, Rivers RPA, Creighton L, Gaffney P: Low dose intraventricular fibrinolytic treatment to prevent posthaemorrhagic hydrocephalus. Arch Dis Child 1992, 67: 12–14.PubMedCrossRefGoogle Scholar
  90. 90.
    Hirsch JF, Pierre-Kahn A, Renier D, et al.: The Dandy-Walker malformation: a review of 40 cases. J Neurosurg 1984, 61:515–522.Google Scholar
  91. 91.
    Hart MN, Malamud N, and Ellis WG: The Dandy-Walker syndrome: a clinicopathological study based on 28 cases. Neurology 1972, 22: 771–780.PubMedCrossRefGoogle Scholar
  92. 92.
    Pascual-Castroviejo I, Velez A, Pascual-Pascual SI, et al.: Dandy-Walker malformation: analysis of 38 cases. Child’s New Syst 1991, 7:88–97.Google Scholar
  93. 93.
    Volpe JJ: Neural Tube Formation and Prosencephalic Development. In Volpe JJ, ed. Neurology of the Newborn. Philadelphia: WB Saunders; 1995: 34–36.Google Scholar
  94. 94.
    Carmel P: The Chiari Malformation and Syringomyelia. In Disorders of the Developing Nervous System: Diagnosis and Treatment. Boston: Blackwell Scientific Publications; 1986: 133–151.Google Scholar
  95. 95.
    Dauser RC, DiPietro MA, Venes JL: Symptomatic Chiari I malformation in childhood: a report of 7 Cases. Pediatr Neurosci 1988, 14: 184–190.PubMedCrossRefGoogle Scholar
  96. 96.
    Levy WJ, Mason L, Hahn JF: Chiari malformation presenting in adults: a surgical experience in 127 cases. Neurosurgery 1983, 12 (4): 377–390.PubMedCrossRefGoogle Scholar
  97. 97.
    Sullivan LP, Stears JC, Ringel SP: Resolution of Syringomyelia and Chiari malformation by ventriculoatrial shunting in a patient with pseudotumor cerebri and a lumboperitoneal shunt. Neurosurgery 1991, 22 (4): 744–747.CrossRefGoogle Scholar
  98. 98.
    McClone DG, Knepper PA: The cause of Chiari II malformation: a unified theory. Pediatr Neurosci 1989, 15: 1–12.CrossRefGoogle Scholar
  99. 99.
    Pascual-Castroviejo I, Villarejo F, Perez-Higueras A, et al.: Childhood choroid plexus neoplasms: a study of 14 cases less than 2 years old. Eur J Pediatr 1983, 140:51–56.Google Scholar
  100. 100.
    Russell DS, Rubinstein LJ: Pathology of Tumors of the Nervous System. Baltimore: Williams & Wilkins; 1989: 394–404.Google Scholar
  101. 101.
    Ho DM, Wong TT, Liu HC: Choroid plexus tumors in childhood: histopathologic study and clinico-pathological correlation. Child’s Nery Syst, 1991, 7: 437–441.CrossRefGoogle Scholar
  102. 102.
    Qualman SJ, Shannon BT, Boesel CP, et al.: Ploidy analysis and cerebrospinal fluid nephelometry as measures of clinical outcome in childhood choroid plexus neoplasia. Pathol Annual 1992, 27(pt1):305–320.Google Scholar
  103. 103.
    Yettou H, Marchal JC, Vinikoff L, et al.: Choroid plexus papillomas in childhood. Report of 11 cases. Neurochirurgie 1994, 40:227–232.Google Scholar
  104. 104.
    Duffner PK, Kun LE, Burger PC, et al.: Postoperative chemotherapy and delayed radiation in infants and very young children with choroid plexus carcinomas. Pediatr Neurosurg 1995, 22:189–196.Google Scholar
  105. 105.
    Greipp M: Klippel-Feil syndrome. Orthoped Nurs 1992, 11: 13–18.CrossRefGoogle Scholar
  106. 106.
    Burke A, Nelson C, Morgan B, Tabin C: Hox genes and the evolution of vertebrate axial morphology. Development 1995, 121 (2): 333–346.PubMedGoogle Scholar
  107. 107.
    Smith C, Tuan R: Human PAX gene expression and development of the vertebral column. Clin Orthop 1994, 302: 241–250.PubMedGoogle Scholar
  108. 108.
    Lemire R, Loeser J, Leach R, Alvord E: Suprasegmental structures, CNS associated structures and related considerations. In Normal and Abnormal Development of the Human Nervous System. Hagerstown, MD: Harper & Row; 1975: 239–392.Google Scholar
  109. 109.
    da Silva E: Preaxial polydactyly and other defects associated with Klippel-Feil anomaly. Hum Hered 1993, 43: 371–374.CrossRefGoogle Scholar
  110. 110.
    Dubey S, Ghosh L: Klippel-Feil syndrome with congenital conductive deafness: report of a case and review of literature. Int J Pediatr Otorhinolaryn 1993, 25: 201–208.CrossRefGoogle Scholar
  111. 111.
    Erbengi A, Oge H: Congenital malformations of the craniovertebral junction: classification and surgical treatment. Acta Neurochir 1994, 127: 180–185.PubMedCrossRefGoogle Scholar
  112. 112.
    Ritterbusch J, McGinty L, Spar J, Orrison W: Magnetic resonance imaging for stenosis and subluxation in Klippel-Feil syndrome. Spine 1991, 16: S539 - S541.PubMedCrossRefGoogle Scholar
  113. 113.
    Rubenstein AH: Neurofibromatosis. A review of the clinical problem in neurofibromatosis. Ann New York Acad Sci. 1986, 486: 1–13.CrossRefGoogle Scholar
  114. 114.
    Crawford AH: Neurofibromatosis in children. Acta Orthoped Scand 1986, 57 (suppl 218): 9–60.CrossRefGoogle Scholar
  115. 115.
    Listernick P, Chauren J, Greenwald M, Mets M: Natural history of optic pathway tumors in children with neurofibromatosis type I: a longitudinal study. J Pediatr 1994, 125 (VI): 63–66.PubMedCrossRefGoogle Scholar
  116. 116.
    Nelson JS: The neuropathology of selected neurocutaneous diseases in seminars in pediatric neurology. Pediat Neuropathol 1995, 2: 192–199.Google Scholar
  117. 117.
    North K: Neurofibromatosis type I: review of the first 200 patients in an Australian clinic. J Child Neurol 1993, 8: 395–402.PubMedCrossRefGoogle Scholar
  118. 118.
    Hochberg FH, DaSilva AB, Galbadini J, et al. Gastrointestinal involvement in von Recklinghausen’s neurofibromatosis. Neurology 1974, 24: 1144–1151.PubMedCrossRefGoogle Scholar
  119. 119.
    National Neurofibromatosis Foundation, 95 Pine Street, 16th Floor, New York, NY 10005; 212–344–6633,212–747–0004,800–323–7938; e–mail; web page HTTP:\\www.nforg.Google Scholar
  120. 120.
    Heim RA, Silverman LM, Farber RA, et al.: Screening for truncated NF-1 proteins. Nat Genet 1994, 8:218–219.Google Scholar
  121. 121.
    Guttman RH, Collins FS: Recent progress toward understanding the molecular biology of von Recklinghausen’s neurofibromatosis. Ann Neurol 1992, 31: 555–561.CrossRefGoogle Scholar
  122. 122.
    Ars E, Serra E, Garcia J, et al.: Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1 [published correction appears in Hum Mol Genet 2000, 9(4):659]. Hum Mol Genet 2000, 9(2):237–247.Google Scholar
  123. 123.
    Wong VC: Clinical manifestations of neurofibromatosis-1 in Chinese children. Pediat Neurol 1994, 11: 301–307.PubMedCrossRefGoogle Scholar
  124. 124.
    DiMario FJ Jr, Langshur S: Headaches in patients with neurofibromatosis-1. J Child Neurol 2000, 15 (4): 235–238.PubMedCrossRefGoogle Scholar
  125. 125.
    Riccardi VM: Neurofibromatosis in neurologic clinics. 1987, 5: 341–349.Google Scholar
  126. 126.
    North K, Joy P, Yuille D, et al.: Specific learning disabilities in children with neurofibromatosis type I: significance of MRI abnormalities. Neurology 1994, 44:878–883.Google Scholar
  127. 127.
    Roach ES, Smith M, Huttenlocher P, et al.: Diagnostic criteria: tuberous sclerosis complex. Diagnostic criteria committee of the national tuberous sclerosis association. J Child Neurol 1992, 7:221–224.Google Scholar
  128. 128.
    Di Mario FT: Brainstem tubers presenting as disordered breathing in tuberous sclerosis complex. J Child Neurol 1995, 10: 407–409.Google Scholar
  129. 129.
    Roach ES: International tuberous sclerosis conference. J Child Neurol 1990, 5: 269–272.PubMedCrossRefGoogle Scholar
  130. 130.
    Bebin EM, Kelly PJ, Gomez MR: Surgical treatment for epilepsy in cerebral tuberous sclerosis. Epilepsia 1993, 4: 651–657.CrossRefGoogle Scholar
  131. 131.
    Webb SW, Osborne JP, Fryer AE: On the incidence of fits and mental retardation in tuberous sclerosis. J Med Genet 1991, 28: 385–388.Google Scholar
  132. 132.
    Shepherd CW, Houser OW, Gomez MR: MR findings in tuberous sclerosis complex and correlation with seizure development and mental impairment. AJNR 1995, 16: 149–155.PubMedGoogle Scholar
  133. 133.
    Hunt A, Shephard C: A prevalence study of autism in tuberous sclerosis. J Autism Dev Disord 1993, 23: 323–329.PubMedCrossRefGoogle Scholar
  134. 134.
    Janssen B, Sampson J, Vander Est M, et al.: Refined localization of TSC by combined analysis of 9834 and 16p13 in 14 tuberous sclerosis families. Hum Genet 1994, 887:1–4.Google Scholar
  135. 135.
    The European chromosome 16 tuberous sclerosis consortium: Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993, (7):1305–1315.Google Scholar
  136. 136.
    Mizuguchi M, Ikeda K, Takashima S: Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis. Acta Neuropathol (Berl) 2000, 99 (5): 503–510.CrossRefGoogle Scholar
  137. 137.
    Lee TC, Sung ML, Chen JS: Tuberous sclerosis associated with neurofibromatosis: report of a case. J Formosa Med Assoc 1994, (9):797–801.Google Scholar
  138. 138.
    National Tuberous Sclerosis Association, 8181 Professional Place, Suite 110, Landover, MD 20785; 800–225-NTSA; e-mail; website HTTP:// Scholar
  139. 139.
    Ito M: Studies of melanin XI. Incontinentia pigmenti achromians, a singular case of nevus depigmentosus systematicus bilateralis. J Exp Med 1972, 55: 57.Google Scholar
  140. 140.
    Lenzini E, Bertoli P, Artifoni L, et al.: Hypomelanosis of Ito: involvement of the chromosome aberrations in this syndrome. Ann Genet 1991, 34(1):30–32.Google Scholar
  141. 141.
    Tunca Y, Wilroy RS, Kadandale JS, et al.: Hypomelanosis of ito and a ‘mirror image’ whole chromosome duplication resulting in trisomy 14 mosaicism. Ann Genet 2000, 43(1):39–43.Google Scholar
  142. 142.
    Wyburn-Mason R: Arteriovenous aneurysm of midbrain, retina, facial naevi and mental changes. Brain 1943, 66: 163.CrossRefGoogle Scholar
  143. 143.
    Davis R, Appen RE: Optic atrophy and the Wyburn-Mason syndrome. J Clin Neuro-Ophthalmol 1984,4(2):91–95.Google Scholar
  144. 144.
    Brom DG, Hilal SK, Tenner MS: Wyburn-Mason syndrome. Report of two cases without retinal involvement. Arch Neurol 1973, 28: 67–68.CrossRefGoogle Scholar
  145. 145.
    Ward JB, Katz NN: Combined phakomatoses: A case report of Sturge-Weber and Wyburn-Mason syndrome occurring in the same individual. Ann Ophthal 1983, 15 (12): 1112–1116.PubMedGoogle Scholar
  146. 146.
    Patel U, Gupta SC: Wyburn-Mason syndrome-a case report and review of the literature. Neuroradiol 1990, 31 (6): 544–546.CrossRefGoogle Scholar
  147. 147.
    Sujansky E, Couradi S: Sturge-Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children. J Child Neurol 1995, 10: 49–58.PubMedCrossRefGoogle Scholar
  148. 148.
    Arzimanoglou A, Aicardi J: The epilepsy of Sturge-Weber syndrome: clinical features and treatment in 23 patients. Acta Neurol Scan (suppl) 1992, 140: 18–22.Google Scholar
  149. 149.
    van Emelen C, Goethals M, Dralands L, Casteels I: Treatment of glaucoma in children with Sturge-Weber syndrome. J Pediatr Ophthalmol Strabismus 2000, 37 (1): 29–34.PubMedGoogle Scholar
  150. 150.
    Roach ES, Riela AR, Chugani HT, et al.: Sturge-Weber syndrome: recommendations for surgery. J Child Neural 1994, 9:190–192.Google Scholar
  151. 151.
    Cohen BA: Incontinentia pigmenti. Neurol Clin North Am 1987, 5: 361–377.Google Scholar
  152. 152.
    Curtis ARJ, Lindsay S, Boye E, et al.: A study of X chromosome activity in two incontinentia pigmenti families with probably linkage to Xq28. Eur J Hum Genet 1994, 2:51–58.Google Scholar
  153. 153.
    Traupe H, Vehring KH: Unstable premutation may explain mosaic disease expression of incontinentia pigmenti in males. Am J Med Genet 1994, 49: 397–398.PubMedCrossRefGoogle Scholar
  154. 154.
    Chatkupt S, Gozo AO, Wolansky LJ, Sun S: Characteristic MR findings in a neonate with incontinentia pigmenti. AJR 1993, 372–374.Google Scholar
  155. 155.
    Yang JH, Ma SY, Tsai CH: Destructive encephalopathy in incontinentia pigmenti: a case report. J Dermatol 1995, 22: 340–343.PubMedGoogle Scholar
  156. 156.
    Pellegrino RJ, Shah AJ: Vascular occlusion associated with incontinentia pigmenti. Pediatr Neurol 1994, 10: 73–74.PubMedCrossRefGoogle Scholar
  157. 157.
    Lee AG, Goldberg MF, Gillard JH: Intracranial assessment of incontinentia pigmenti using magnetic resonance imaging angiography and spectroscopic imaging. Arch Pediatr Adolesc Med 1995, 149: 573–580.PubMedCrossRefGoogle Scholar
  158. 158.
    Wald KJ, Mehta MC, Katsumi O, et al.: Retinal detachments in incontinentia pigmenti. Arch Opthalmol 1993, 111:614–617.Google Scholar
  159. 159.
    Barton L, Budd S, Morfitt W, et al.: Congenital lymphocytic choriomeningitis virus infection in twins. Pediatr Infect Dis J 1993, 12:942–946.Google Scholar
  160. 160.
    Perlman J, Argyle C: Lethal cytomegalovirus infection in preterm infants: clinical, radiological and neuropathological findings. Ann Neurol 1992, 31: 64–68.PubMedCrossRefGoogle Scholar
  161. 161.
    Gressens P, Hill J, Paindaveine B, et al.: Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse. J Clin Invest 1994, 94:2020–2027.Google Scholar
  162. 162.
    Sugimoto T, Yashuhara A, Nishida N, et al.: MRI of the head in the evaluation of microcephaly. Neuropediatrics 1993, 24:4–7.Google Scholar
  163. 163.
    Jones KL, ed: Smith’s Recognizable Patterns of Human Malformations. Philadelphia: WB Saunders; 1988: 10–15.Google Scholar
  164. 164.
    Committee on Sports Medicine & Fitness, American Academy of Pediatrics: Atlantoaxial instability in Down syndrome: subject review. Pediatrics 1995, 96: 151–154.Google Scholar
  165. 165.
    Harley EH, Collins MD: Neurologic sequelae secondary to atlanto-axial instability in Down syndrome. Arch Otolaryngol Head Neck Surg 1994, 120: 159–165.PubMedCrossRefGoogle Scholar
  166. 166.
    Chaudhry V, Sturgeon C, Gates AJ, Myers G: Symptomatic atlanto-axial dislocation in Down syndrome. Ann Neurol 1987, 21: 606–609.PubMedCrossRefGoogle Scholar
  167. 167.
    Selby KA, Newton RW, Gupta S, Hunt L: Clinical predictors and radiological reliability in atlanto-axial subluxation in Down syndrome. Arch Dis Child 1991, 66: 876–878.PubMedCrossRefGoogle Scholar
  168. 168.
    Smith MD, Phillips WA, Hensinger RN: Fusion of the upper cervical spine in children and adolescents. An analysis of 17 patients. Spine 1991, 16: 695–701.PubMedCrossRefGoogle Scholar
  169. 169.
    Neufeld EF, Muenzer J: The Mucopolysaccharidoses. In The Metabolic and Molecular Bases of Inherited Disease. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D: New York: McGraw-Hill, 1995, 2465–2494.Google Scholar
  170. 170.
    Kornfeld S, Sly WS: I-Cell Disease and Pseudo-Hurler Polydystrophy: Disorders of Lysosomal Enzyme Phosphorylation and Localization. In The Metabolic and Molecular Bases of Inherited Disease. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-Hill, 1995: 2495–2508.Google Scholar
  171. 171.
    Thomas GH, Beaudet AL: Disorders of Glycoprotein Degradation and Structure: a-Mannosidosis, ß-Mannosidosis, Fucosidosis, Sialidosis, Aspartylglucosaminuria, and Carbohydrate-deficient Glycoprotein Syndrome. In The Metabolic and Molecular Bases of Inherited Disease. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-Hill, 1995: 2529–2561.Google Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Suresh Kotagal
  • Alma R. Bicknese
  • Marthand Eswara
  • Glen A. Fenton
  • Thomas J. Geller
  • Dorothy K. Grange
  • David S. Martin
  • Michael A. Nigro
  • Thomas Pittman

There are no affiliations available

Personalised recommendations